Bio-Techne TECH
NASDAQ TECH
$72.41 +0.01 (+0.01%)
As of: Oct 2, 2026 · 2:15 PM EDT

Bio-Techne (TECH) Asset Writedowns and Impairment (2012 - 2025)

Updated

Bio-Techne (TECH) reported Asset Writedowns and Impairment of $84.16 million for fiscal Q4 2025 (quarter ended Jun 30, 2025), up 428.5% from $15.93 million a year earlier.

Analysis

Bio-Techne (TECH) Asset Writedowns and Impairment (2012 - 2025) Analysis & Trends

For FY2025 (ended Jun 30, 2025), Bio-Techne posted Asset Writedowns and Impairment of $80.5 million, up 266.5% from FY2024.

  • Asset Writedowns and Impairment has a three-year compound annual growth rate of 62.6% (FY2022 to FY2025).
  • By fiscal year, Asset Writedowns and Impairment came in at $21.96 million in FY2024 and $18.72 million in FY2022.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Thermo Fisher Scientific 249.71 Bn 228.86 Bn 4.88 Bn
2 Abbott Laboratories 171.00 Bn 142.08 Bn 7.27 Bn
3 Danaher 155.79 Bn 139.61 Bn 3.61 Bn
4 Intuitive Surgical 143.91 Bn 123.46 Bn 1.96 Bn
5 Medtronic 110.42 Bn 76.29 Bn 6.34 Bn
6 Stryker 105.71 Bn 91.82 Bn 4.50 Bn
7 Boston Scientific 63.26 Bn 58.27 Bn 3.85 Bn
8 Edwards Lifesciences 49.80 Bn 33.91 Bn 1.35 Bn
9 Becton Dickinson 48.78 Bn 45.93 Bn 2.32 Bn
10 Bio-Techne 11.31 Bn 10.52 Bn 211.39 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2025 84.16 Mn
Mar 31, 2025 -3.66 Mn
Jun 30, 2024 15.93 Mn
Dec 31, 2021 18.72 Mn
Sep 30, 2021 546,000.00
Mar 31, 2018 16.25 Mn
Mar 31, 2012 3.25 Mn
API Access

Bio-Techne Asset Writedowns and Impairment API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=asset-writedowns-and-impairment&ticker=TECH&period=max&api_key=YOUR_API_KEY